
Learning targets: Children, risky words, intranasal, ingredient benefits
Use caution copy & pasting “ingredient benefits” onto commercial website
Warning Letter Wednesday is a cautionary tale for companies new to the space that are looking to market products.
This company looks like a groovy crystal shop that started making topical products and products delivered to the eyes and nose.
So what can we learn?
Of course, there are high risks words referenced in the warning letter, Notably, the use of viruses, cancer, and so many more!
Products delivered through the nose (intranasal) or as an eye drop are drugs and have a justifiable higher level of scrutiny.
Products marketed for use by children are high-risk.
This warning letter is a good teaching tool. Copying and pasting a product’s “therapeutic uses” from a textbook or website is a great way to get into trouble. This appears to be the case here.
From warning letter: Colloidal silver is used to treat infections due to yeast; bacteria (tuberculosis, Lyme disease, bubonic plague, pneumonia, leprosy, gonorrhea, syphilis, scarlet fever, stomach ulcers, cholera); parasites (ringworm, malaria); and viruses (HIV/AIDS, pneumonia, herpes, shingles, warts).
From warning letter: “…. to heal skin irritations and scarring.”
Read the warning letter here.
In closing, I think the FDA would have left this company alone if there were not talking about viruses, selling products that go into the nose and eyes, are marketed as safe for children, and had just too many disease words to be avoided.
I started a LinkedIn group just for warning letter discussion. Join here.